Institut Català d'Oncologia

Girona 17007

0 studies enrolling now · 2 studies all time

What they study most

Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed